Bayer AGBAYRY
OTC • Healthcare
$11.06
P/E
—
PEG
—
FCF Yield
—
Rev Growth YoY
-3.4% YoY
Gross Margin
60.6%
Health Score
5/10
D/E Ratio
1.44
Confidence
MEDIUM
Business Snapshot
Bayer AG is a German multinational pharmaceutical and life sciences company operating in the Drug Manufacturers - General industry. It competes globally across pharmaceuticals, consumer health, and crop science, with a diversified portfolio that includes prescription drugs, over-the-counter products, and agricultural solutions. With trailing twelve-month revenue of $45.47B, the company is a large-cap entity even though its market capitalisation is not reported in the available data. A defining characteristic is the ongoing legal overhang from glyphosate-based product liabilities, which has weighed on investor sentiment and contributed to the stock’s depressed valuation relative to historical levels.
Financial Health
Gross margin improved year-over-year to 60.6% (from 55.4%), signalling better cost control or product mix, but net margin remains deeply negative at -7.9% due to persistent net losses totaling $-3.58B in TTM net income. The balance sheet is moderately leveraged with a debt-to-equity ratio of 1.44x, while the current ratio of 1.0x provides minimal short-term liquidity buffer...
Risk Assessment
- PROFITABILITY — Net margin of -7.9% reflects ongoing GAAP losses despite improving gross margins, with TTM net income of $-3.58B.
- VALUATION — EV/EBITDA of 19.97x is high relative to a 3.4% revenue decline, suggesting the market is pricing in future recovery that may not materialise.
- DEBT / LIQUIDITY — Current ratio of 1.0x offers only a minimal cushion against short-term obligations, leaving limited flexibility.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
- DCF UNCERTAINTY — The FMP DCF fair value of $62.01 suggests deep undervaluation, but the Python DCF could not be computed due to negative FCF, creating a wide uncertainty band around any intrinsic value estimate....